1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RP11-762I7.5 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA CDRT15L2 CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA C19orf45 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ETHE1 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA KIR2DL3 CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA IL17D CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA JARID2 CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA RECK CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA ITSN2 CTRPv2 pan-cancer AAC -0.14 0.0005
mRNA MISP CTRPv2 pan-cancer AAC 0.15 0.0005
Download CSV